Review of the UK Government’s 2005 Framework for Good Practice in the Pharmaceutical Industry

In 2005, the UK Department for International Development (DFID), the UK
Department of Health (DH) and the then UK Department of Trade and Industry, published a policy paper that set out a framework for pharmaceutical companies on good practice in increasing access to medicine in developing countries.

This review focuses on the research-based industry but the role of the generic industry has also been considered. It draws on desk-based research and key informant interviews with representatives of the UK

Government, major pharmaceutical companies and associations, and other key stakeholder groups. The review will serve as a background paper to inform the UK Government’s next steps in its work with the pharmaceutical industry and other stakeholders, such as investors, technical agencies and civil society organisations. Download the Review of the UK Government's 2005 Framework for Good Practivce in the Pharmaceutical Industry.